Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Angiopoietin-1 | 1 | 2017 | 25 | 0.69 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.61 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.43 | Why? |
| Thoracic Surgery | 1 | 2017 | 623 | 0.39 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.36 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.33 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.28 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.27 | Why? |
| Lung Neoplasms | 2 | 2019 | 3228 | 0.26 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.25 | Why? |
| Tomography, X-Ray Computed | 6 | 2020 | 25144 | 0.24 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.22 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.22 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.22 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.22 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.21 | Why? |
| Pneumonia, Ventilator-Associated | 2 | 2018 | 861 | 0.21 | Why? |
| Endodeoxyribonucleases | 1 | 2021 | 149 | 0.20 | Why? |
| Lung | 8 | 2021 | 31049 | 0.20 | Why? |
| China | 15 | 2021 | 50654 | 0.20 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 1 | 2019 | 44 | 0.19 | Why? |
| Neisseria | 1 | 2017 | 9 | 0.18 | Why? |
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 10 | 0.18 | Why? |
| Neisseriaceae Infections | 1 | 2017 | 21 | 0.18 | Why? |
| CRISPR-Associated Proteins | 1 | 2021 | 258 | 0.18 | Why? |
| Chemokine CXCL2 | 1 | 2017 | 21 | 0.18 | Why? |
| Enterobacter cloacae | 1 | 2017 | 58 | 0.18 | Why? |
| Streptococcus | 1 | 2017 | 76 | 0.17 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.17 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.17 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 176 | 0.16 | Why? |
| Neutrophil Infiltration | 1 | 2017 | 201 | 0.16 | Why? |
| Pseudomonas aeruginosa | 2 | 2018 | 652 | 0.16 | Why? |
| Stem Cell Transplantation | 1 | 2021 | 531 | 0.15 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.15 | Why? |
| Capillary Permeability | 1 | 2017 | 277 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.14 | Why? |
| Stem Cells | 1 | 2021 | 595 | 0.14 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.14 | Why? |
| Bacterial Proteins | 2 | 2021 | 1318 | 0.14 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.13 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.13 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.13 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.13 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2018 | 1115 | 0.12 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.12 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Elastin | 1 | 2011 | 16 | 0.12 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.11 | Why? |
| Transforming Growth Factor beta1 | 2 | 2011 | 204 | 0.11 | Why? |
| Radiology Department, Hospital | 1 | 2020 | 805 | 0.11 | Why? |
| Legionnaires' Disease | 1 | 2013 | 108 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.11 | Why? |
| Interleukin-10 | 2 | 2017 | 1409 | 0.11 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Immunization, Passive | 3 | 2020 | 10067 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2017 | 2309 | 0.10 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.10 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3832 | 0.10 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.10 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.09 | Why? |
| Mice, Inbred C57BL | 2 | 2017 | 5542 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.09 | Why? |
| Adult | 13 | 2021 | 244371 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.09 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.09 | Why? |
| Fibroblasts | 1 | 2011 | 839 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.08 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.08 | Why? |
| Male | 20 | 2021 | 367725 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.07 | Why? |
| Female | 19 | 2021 | 380317 | 0.07 | Why? |
| Animals | 6 | 2021 | 78931 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.06 | Why? |
| Mice | 3 | 2021 | 21357 | 0.06 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.06 | Why? |
| Aged | 11 | 2021 | 215776 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.06 | Why? |
| Mice, Inbred NOD | 1 | 2021 | 134 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.06 | Why? |
| RNA Probes | 1 | 2021 | 106 | 0.06 | Why? |
| Mice, SCID | 1 | 2021 | 225 | 0.05 | Why? |
| Macrophages | 1 | 2013 | 2784 | 0.05 | Why? |
| Heterografts | 1 | 2021 | 203 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Spectrometry, Fluorescence | 1 | 2021 | 177 | 0.05 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Connective Tissue | 1 | 2018 | 8 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Ethanolaminephosphotransferase | 1 | 2017 | 2 | 0.05 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.05 | Why? |
| Fever | 3 | 2020 | 7795 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.04 | Why? |
| Ciliary Motility Disorders | 1 | 2018 | 58 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Fluorescent Dyes | 1 | 2021 | 536 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Cough | 2 | 2020 | 4891 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.03 | Why? |
| Leukocyte Count | 2 | 2020 | 3178 | 0.03 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.03 | Why? |
| Neuronal Apoptosis-Inhibitory Protein | 1 | 2013 | 1 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Dexamethasone | 1 | 2005 | 2055 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2021 | 1394 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2021 | 1289 | 0.03 | Why? |
| U937 Cells | 1 | 2013 | 77 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Nucleocapsid Proteins | 1 | 2005 | 3120 | 0.03 | Why? |
| Caspases | 1 | 2013 | 156 | 0.03 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.03 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Tropoelastin | 1 | 2011 | 1 | 0.03 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2013 | 202 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Legionella pneumophila | 1 | 2013 | 143 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
| beta-Lactamases | 1 | 2017 | 759 | 0.03 | Why? |
| Cell Death | 1 | 2013 | 536 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.03 | Why? |
| Biomarkers, Tumor | 1 | 2019 | 1314 | 0.03 | Why? |
| Glucocorticoids | 1 | 2005 | 4431 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Inflammasomes | 1 | 2013 | 710 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2013 | 3608 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Cell Proliferation | 1 | 2011 | 1973 | 0.02 | Why? |
| Transforming Growth Factor beta | 1 | 2005 | 363 | 0.02 | Why? |
| Family | 1 | 2017 | 2909 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Inflammation | 1 | 2005 | 13255 | 0.02 | Why? |
| Random Allocation | 1 | 2005 | 773 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Apoptosis | 1 | 2013 | 2335 | 0.02 | Why? |
| Rats, Sprague-Dawley | 1 | 2005 | 987 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.01 | Why? |
| Monocytes | 1 | 2013 | 2978 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Cells, Cultured | 1 | 2011 | 5835 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Rats | 1 | 2005 | 2764 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Interleukin-6 | 1 | 2005 | 7522 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
Qu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(385)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_